创建和评估评分来评估过量服用:OD评分
Kazuki Nagashima1,2, Nobuhiro Yasuno3, Machiko Watanabe4
1Laboratory of Practical Pharmacy, Graduate School and Faculty of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8675, Japan. knagashima@chiba-u.jp.
BMC emergency medicine
|January 7, 2024
概括
一个新的OD得分准确地识别了过量服用患者,即使是在灾难期间被压倒的急诊室. 这种工具有助于非专注于过量治疗的设施.
科学领域:
- 紧急医疗 紧急医疗
- 毒理学 毒理学 毒理学
- 临床评分系统 临床评分系统
背景情况:
- 应急部门在流行病等灾难期间面临能力问题,影响护理.
- 在紧急情况下增加的压力导致过量服用病例的增加.
- 缺乏用于过量剂量评估的标准化评分系统带来了挑战.
研究的目的:
- 开发和验证用于过量剂量评估的患者特定评分系统.
- 在紧急情况下提高过量剂量识别的准确性和效率.
主要方法:
- 回顾性单一中心研究评估基于证据的OD得分 (0-15).
- 使用了后勤分析和接收机运行特征 (ROC) 曲线分析.
- 外部验证是在单独的患者队列上进行的.
主要成果:
- 该OD得分显示高准确度,切线为8 (AUC:0.99),正确识别过量患者.
- 过量服用的关键预测因素包括发现场景和最近的精神焦虑.
- 在外部验证中,OD得分表现出色 (AUC:1.0).
结论:
- 开发的OD评分是评估过量服用患者的可靠工具.
- 这种评分系统对于在管理过量用药病例方面经验有限的医疗机构来说尤其有益.
更多相关视频
相关概念视频
Dose-Response Relationship: Overview
3.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.1K
Agonism and Antagonism: Quantification
377
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
377
Odds Ratio
139
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
139
Pharmacovigilance
838
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
838
Drug Abuse and Addiction: Pharmacological Phenomena
479
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
479
Dose-Response Relationship: Potency and Efficacy
4.4K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.4K


